SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 263 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 18 | -87.3% | 0.00% | – |
| Q2 2022 | $4,000 | +100.0% | 142 | +71.1% | 0.00% | – |
| Q1 2022 | $2,000 | -77.8% | 83 | -74.9% | 0.00% | – |
| Q4 2021 | $9,000 | +50.0% | 331 | +5.1% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 315 | +25.5% | 0.00% | – |
| Q2 2020 | $6,000 | -25.0% | 251 | -44.6% | 0.00% | – |
| Q1 2020 | $8,000 | +166.7% | 453 | +248.5% | 0.00% | – |
| Q4 2019 | $3,000 | -91.7% | 130 | -89.9% | 0.00% | – |
| Q3 2019 | $36,000 | -18.2% | 1,293 | -2.3% | 0.00% | -100.0% |
| Q2 2019 | $44,000 | +15.8% | 1,323 | +22.3% | 0.00% | 0.0% |
| Q1 2019 | $38,000 | +245.5% | 1,082 | +232.9% | 0.00% | – |
| Q4 2018 | $11,000 | -31.2% | 325 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -15.8% | 325 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | – | 325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |